4.6 Article

Detection and quantification of dengue virus using a novel biosensor system based on dengue NS3 protease activity

期刊

PLOS ONE
卷 12, 期 11, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0188170

关键词

-

资金

  1. National Health Research Institutes [IV-105-PP-03, IV-104-PP-16]

向作者/读者索取更多资源

Background The traditional methods, plaque assays and immuno-focus assays, used to titrate infectious dengue virus (DENV) particles are time consuming and labor intensive. Here, we developed a DENV protease activity detection system (DENPADS) to visualize DENV infection in cells based on dengue protease activity. Methodology/Principal findings Dengue NS3 protease cleaves NS4B-NS5. BHK-21 cells stably expressing the sensor module comprising DENV-2 NS4 and the 10 amino-terminal amino acids of NS5 ((N10)NS5) fused with the SV40 nuclear localization signal (NLS) and Cre recombinase (Cre), were generated. Cre is constrained outside the nucleus in the absence of NS3 activity but translocates into the nucleus through NS4B-NS5 cleavage when cells are infected with DENV. Nuclear translocation of Cre can trigger the reporter system, which contains a cis-loxP-flanked mCherry with three continuous stop codons following an SV40 polyA tail cDNA upstream of EGFP or mHRP cDNA. Our results show that DENPADS is an efficient and accurate method to titrate 4 DENV serotypes in 24 hours. Compared with current virus titration methods, the entire process is easy to perform, and the data are easily acquired. Conclusions/Significance In this study, we demonstrate that DENPADS can be used to detect dengue viral infection through a fluorescence switch or HRP activity in the infected cells. This approach is sensitive with less incubation time and labor input. In addition, DENPADS can simultaneously evaluate the efficacy and cytotoxicity of potential anti-DENV candidates. Overall, DENPADS is a useful tool for dengue research.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases

Jing-Xing Yang, Jen-Chih Tseng, Guann-Yi Yu, Yunping Luo, Chi-Ying F. Huang, Yi-Ren Hong, Tsung-Hsien Chuang

Summary: Vaccines are important for controlling microbial infections and preventing epidemic diseases. The development of adjuvants, specifically Toll-like receptor (TLR) agonists, has seen significant progress in recent years for human vaccines. The COVID-19 pandemic has also accelerated the clinical research of TLR agonist-based adjuvants. This paper reviews the agonists for TLR activation and their molecular mechanisms, with a focus on recent advances in TLR agonist-based vaccine adjuvants for infectious diseases.

PHARMACEUTICS (2022)

Article Biochemistry & Molecular Biology

Low-Dose SARS-CoV-2 S-Trimer with an Emulsion Adjuvant Induced Th1-Biased Protective Immunity

Hung-Chun Liao, Wan-Ling Wu, Chen-Yi Chiang, Min-Syuan Huang, Kuan-Yin Shen, Yu-Ling Huang, Suh-Chin Wu, Ching-Len Liao, Hsin-Wei Chen, Shih-Jen Liu

Summary: During the COVID-19 pandemic, global mass vaccination is crucial for achieving herd immunity. The study shows that the S-Trimer vaccine, when adjuvanted with SWE, induces strong antibody and cellular immune responses, providing neutralizing antibodies against the original and variant strains of SARS-CoV-2. Additionally, the SWE adjuvant allows for a lower vaccine dosage while maintaining effectiveness.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Immunology

A novel chimeric dengue vaccine candidate composed of consensus envelope protein domain III fused to C-terminal-modified NS1 protein

Hong-Jyun Huang, Martyr Yang, Hsin-Wei Chen, Shuying Wang, Chih-Peng Chang, Tzong-Shiann Ho, Yu-San Kao, Sen-Mao Tien, Hsing-Han Lin, Po-Chun Chang, Yen-Chung Lai, Yu-Peng Hsiao, Yi-Ling Liu, Chiao-Hsuan Chao, Robert Anderson, Trai-Ming Yeh, Yee-Shin Lin, Shu-Wen Wan

Summary: This study developed a modified DENV vaccine candidate with enhanced features by combining modifications of two DENV proteins. The vaccine candidate showed protective effects against DENV infection in a mouse model, indicating its potential clinical application.

VACCINE (2022)

Article Immunology

Furin and TMPRSS2 Resistant Spike Induces Robust Humoral and Cellular Immunity Against SARS-CoV-2 Lethal Infection

Jhe-Jhih Lin, Chih-Feng Tien, Yi-Ping Kuo, En-Ju Lin, Wei-Hsiang Tsai, Ming-Yu Chen, Pei-Ju Tsai, Yu-Wen Su, Nikhil Pathak, Jinn-Moon Yang, Chia-Yi Yu, Zih-Shiuan Chuang, Han-Chieh Wu, Wan-Ting Tsai, Shih-Syong Dai, Hung-Chun Liao, Kit Man Chai, Yu-Siang Su, Tsung-Hsien Chuang, Shih-Jen Liu, Hsin-Wei Chen, Horng-Yunn Dou, Feng-Jui Chen, Chiung-Tong Chen, Chin-Len Liao, Guann-Yi Yu

Summary: An effective COVID-19 vaccine against broad SARS-CoV-2 variants is still needed. This study used a vesicular stomatitis virus (VSV)-based vector to express the SARS-CoV-2 Spike protein for better vaccine designs. The recombinant VSV-spike virus with C-terminal 19 amino acid truncation (S Delta 19 Rep) induced protective immunity against SARS-CoV-2 infection in hamsters. Mutations blocking enzymatic processing of the Spike protein were identified and found to enhance immune responses. Vaccination with the mutated virus provided high antibody response and protection against a lethal SARS-CoV-2 challenge.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

A DNA vaccine candidate delivered by an electroacupuncture machine provides protective immunity against SARS-CoV-2 infection

Tsai-Teng Tzeng, Kit Man Chai, Kuan-Yin Shen, Chia-Yi Yu, Shiu-Ju Yang, Wan-Chun Huang, Hung-Chun Liao, Fang-Feng Chiu, Horng-Yunn Dou, Ching-Len Liao, Hsin-Wei Chen, Shih-Jen Liu

Summary: This study reports an electroacupuncture machine-based method for DNA vaccine delivery of the COVID-19 DNA vaccine. The method was found to efficiently induce neutralizing antibodies and Th1-biased immune responses in mice and provide protection against SARS-CoV-2 challenge in hamsters. T-cell epitope mapping revealed specific regions of reactivity. The method was deemed safe based on preclinical toxicology studies, and the raised antisera showed cross-neutralization against different variants of concern.

NPJ VACCINES (2022)

Article Medicine, Research & Experimental

Monoclonal antibody targeting the conserved region of the SARS-CoV-2 spike to overcome viral variants

Wan-Ling Wu, Chen-Yi Chiang, Szu-Chia Lai, Chia-Yi Yu, Yu-Ling Huang, Hung-Chun Liao, Ching-Len Liao, Hsin-Wei Chen, Shih-Jen Liu

Summary: Most therapeutic monoclonal antibodies (mAbs) target the receptor-binding domain (RBD) of SARS-CoV-2 spike protein, which is prone to mutations in variants. However, we identified mAbs that recognize the non-mutated S2 region of the spike protein and can neutralize SARS-CoV-2 infection and protect animals. Humanization of variable region sequences led to the selection of a high-affinity humanized mAb, hMab5.17, which effectively neutralized both SARS-CoV-2 and its variants. This suggests that an mAb targeting the S2 region could serve as a potential universal therapeutic for COVID-19.

JCI INSIGHT (2022)

Article Multidisciplinary Sciences

Glycosylation and S-palmitoylation regulate SARS-CoV-2 spike protein intracellular trafficking

Chih-Feng Tien, Wan-Ting Tsai, Chun Hwa Chen, Hui-Ju Chou, Mingzi M. Zhang, Jhe-Jhih Lin, En-Ju Lin, Shih-Syong Dai, Yueh-Hsin Ping, Chia-Yi Yu, Yi-Ping Kuo, Wei-Hsiang Tsai, Hsin-Wei Chen, Guann-Yi Yu

Summary: Post-translational modifications play critical roles in protein folding, stability, trafficking, and function. This study investigates the impact of glycosylation and palmitoylation on the maturation and infectivity of SARS-CoV-2 spike protein. The results show that mutations in specific motifs alter intracellular trafficking, glycosylation pattern, and infectivity of pseudoviruses, highlighting the importance of these modifications in the fusion and infection mediated by the S protein.

ISCIENCE (2022)

Article Virology

Omicron-specific mRNA vaccine induced cross-protective immunity against ancestral SARS-CoV-2 infection with low neutralizing antibodies

Kuan-Yin Shen, Chung-Hsiang Yang, Chiung-Tong Chen, Hui-Min Ho, Fang-Feng Chiu, Chiung-Yi Huang, Hung-Chun Liao, Chia-Wei Hsu, Guann-Yi Yu, Ching-Len Liao, Hsin-Wei Chen, Ming-Hsi Huang, Shih-Jen Liu

Summary: The major challenge in COVID-19 vaccine effectiveness is immune escape by SARS-CoV-2 variants. An Omicron-specific mRNA vaccine was designed to overcome this challenge. Animal studies showed that the vaccine generates non-neutralizing antibodies or cellular immunity that can recognize both Wuhan and Omicron variants, providing protection against Wuhan virus challenge.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Pharmacology & Pharmacy

Formulation of SARS-CoV-2 Spike Protein with CpG Oligodeoxynucleotides and Squalene Nanoparticles Modulates Immunological Aspects Following Intranasal Delivery

Hui-Min Ho, Chiung-Yi Huang, Chung-Hsiang Yang, Shih-Jen Liu, Hsin-Wei Chen, Guann-Yi Yu, Jen-Kun Chen, Tsung-Hsien Chuang, Ming-Hsi Huang

Summary: Nasal spray vaccination is a promising strategy for inducing protection against respiratory SARS-CoV-2 coronavirus. This study demonstrates the potential of PELC:CpG as a mucosal adjuvant that enhances immune responses and cell-mediated immunity, which has implications for the development of a nasal spray vaccine against COVID-19.

PHARMACEUTICS (2022)

Article Immunology

Recombinant lipidated FLIPr effectively enhances mucosal and systemic immune responses for various vaccine types

Ming-Shu Hsieh, Mei-Yu Chen, Chia-Wei Hsu, Yu-Wen Tsai, Fang-Feng Chiu, Cheng-Lung Hsu, Chang-Ling Lin, Chiao-Chieh Wu, Ling-Ling Tu, Chen-Yi Chiang, Shih-Jen Liu, Ching-Len Liao, Hsin-Wei Chen

Summary: Formyl peptide receptor-like 1 inhibitor protein (FLIPr) is a potential vaccine candidate produced by Staphylococcus aureus for reducing its virulence and biofilm formation. Recombinant lipidated FLIPr (rLF) was produced to increase its immunogenicity and showed to elicit potent anti-FLIPr responses and overcome FLIPr-mediated inhibition of phagocytosis. Additionally, rLF acts as an effective adjuvant by inducing strong and long-lasting immune responses in mice, supporting its potential use to enhance vaccine efficacy and abolish FLIPr-mediated immunosuppressive effects.

NPJ VACCINES (2023)

Article Virology

Co-delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1-dominant humoral and cellular immunity against SARS-CoV-2

Hung-Chun Liao, Min-Syuan Huang, Fang-Feng Chiu, Kit Man Chai, Ching-Len Liao, Suh-Chin Wu, Hsin-Wei Chen, Shih-Jen Liu

Summary: This study reports a novel COVID-19 vaccine that combines recombinant S protein with a DNA vaccine. The combination vaccine induces strong T-cell immune response and enhances immune indicators such as antibody titers. In animal experiments, hamsters vaccinated with the combination vaccine showed no weight loss and had low viral load in the lungs, indicating the important role of this vaccine in disease control.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Medicine, General & Internal

Mechanical transmission of dengue virus by Aedes aegypti may influence disease transmission dynamics during outbreaks

Hsing-Han Li, Matthew P. Su, Shih-Cheng Wu, Hsiao-Hui Tsou, Meng-Chun Chang, Yu-Chieh Cheng, Kuen-Nan Tsai, Hsin-Wei Wang, Guan-Hua Chen, Cheng-Kang Tang, Pei -Jung Chung, Wan-Ting Tsai, Li-Rung Huang, Yueh Andrew Yueh, Hsin-Wei Chen, Chao-Ying Pan, Omar S. Akbari, Hsiao-Han Chang, Guann-Yi Yu, John M. Marshall, Chun-Hong Chen

Summary: A study using a mouse model revealed the potential of mechanical transmission of dengue virus, independent of viral replication in mosquitoes. This finding suggests the possibility of larger outbreaks and has implications for vector control strategies. It also raises the possibility of similar mechanical transmission routes in other disease-carrying mosquitoes.

EBIOMEDICINE (2023)

Article Cell Biology

Induction of high affinity monoclonal antibodies against SARS-CoV-2 variant infection using a DNA prime-protein boost strategy

Chen-Yi Chiang, Mei-Yu Chen, Chia-Wei Hsu, Chia-Yeh Liu, Yu-Wen Tsai, Hung-Chun Liao, Jia-Ying Yan, Zih-Shiuan Chuang, Hsin- Wang, Chien-Hsiung Pan, Chia-Yi Yu, Guann-Yi Yu, Ching-Len Liao, Shih-Jen Liu, Hsin-Wei Chen

Summary: This study generated high-quality monoclonal antibodies using a DNA prime-protein boost approach and found that one antibody displayed the best potency in terms of binding affinity and neutralizing capacity. This antibody was able to protect animals from SARS-CoV-2 infection. The results suggest that a combination of multiple monoclonal antibodies may be the best strategy for treating future SARS-CoV-2 variant outbreaks.

JOURNAL OF BIOMEDICAL SCIENCE (2022)

Article Biochemistry & Molecular Biology

High-Integrity Sequencing of Spike Gene for SARS-CoV-2 Variant Determination

Yu-Chieh Liao, Feng-Jui Chen, Min-Chieh Chuang, Han-Chieh Wu, Wan-Chen Ji, Guann-Yi Yu, Tsi-Shu Huang

Summary: The widely used amplicon-based approach for SARS-CoV-2 genome sequencing has limitations, including low sequence coverage and high resource requirements. To address these issues, the researchers proposed a single PCR method to efficiently detect spike gene mutations and developed a bioinformatic protocol for accurate variant calling of spike protein. Their approach showed high detection rates and robustness against different sequencing datasets.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

暂无数据